The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit:http://www.clintonhealthaccess.org.
Overview of CHAI's Vaccines program
Immunization is one of the most successful public health interventions in history. National immunization programs reach >100 million infants every year and have averted globally two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974 , whilst the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1 million lives per year. Furthermore, great advances in discovering and financing new vaccines provides a great opportunity for countries to further reduce burden of disease such as human papillomavirus (HPV). Despite these successes, 1.5 million children still die each year of vaccine-preventable diseases, many of them in low-income countries, as immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative (CHAI) has worked to save lives and reduce the burden from vaccine preventable diseases by improving access to immunization services in resource-limited setting by strengthening national immunization programs and by leveraging its experience in-country to improve the global immunization ecosystem. CHAI is pursuing six complementary strategic goals:
CHAI's vaccine program very closely supports the national immunization programs in 14 focus countries - Cameroon, Ethiopia, India, Indonesia, Kenya, Lao PDR, Lesotho, Nigeria, Papua New Guinea, Tanzania, Sierra Leone, Uganda, Vietnam and Zimbabwe- and also engages with global stakeholders such as Gavi, WHO and UNICEF to inform global policies and practices.
Despite significant gains made in immunization coverage from 21% in 1980, global DTP3 coverage has stalled at approximately 85% since 2010, while in 2018 DTP3 coverage in West and Central Africa stagnated at 70%, and in East and Central Africa was at 81%. As a result, nearly one quarter of children under-5 in the region are under- or unimmunized. Immunization coverage is generally much lower for vaccines that are delivered via weaker or complex delivery platforms, such as maternal, neonatal, 9-month, second year and adolescent - whether current vaccines or those slated for introduction. For example, West and Central Africa has stagnated at ~70% measles conjugate vaccine / measles rubella vaccine first dose (MCV1/MR1) coverage since 2010.
CHAI will provide support to countries in strengthening decision-making for the introduction of new vaccines, securing resources (e.g. from Gavi) for introduction support, and planning appropriately for introductions in order to achieve high coverage swiftly and sustainably. In particular, CHAI will focus on support in Gavi-eligible countries that have yet to introduce HPV, PCV, and Rota, and consider future introductions of upcoming Gavi supported vaccines. CHAI will also develop, test, and scale innovative service delivery interventions in focus countries, with the objective to increase coverage in priority populations in a way that can be scaled and sustained by governments. CHAI will support governments to (i) improve the planning and the performance management of immunization sessions; (ii) improve the linkages of maternal and newborn health services with immunization to increase routine immunization coverage and strengthen the neonatal platform used for OPV, BCG, and HepB birth dose; (iii) increase the routine coverage of the nine-month platform (when vaccines against measles, yellow fever, meningitis A or Typhoid should be administered); and (iv) develop better informed coverage plans and support the implementation of key service delivery strategies to target unimmunized children. CHAI will distill the tools and lessons learned from this work in focus countries and disseminate them to the global community.
Location: This role has flexibility to be based in a CHAI program country, pending country team leadership approval. Base location in a sub-Saharan Africa program country is strongly preferred.
As part of the Global Vaccines Delivery team the Manager, New Vaccine Introductions and Service Delivery (NVISD), will work in collaboration with his/her direct reports, country and program leadership to: (i) support program and grant management, (ii) develop CHAI's vaccines program in the area of new vaccine introductions and service delivery for immunization, (iii) provide strategic and programmatic support for the design and implementation of work in focus countries, and (iv) improve national and global practices and policies related to new vaccine introductions and service delivery. His/her work will help to achieve and sustain immunization program outcomes, and also serve as a blueprint to identify powerful interventions to improve health systems which could be adapted for other primary health care programs.
1) Support program and grant management, in collaboration with program and country leadership
2) Develop CHAI's vaccines program in the area of new vaccine introduction and immunization service delivery, in collaboration with program and country leadership
3) Provide strategic and programmatic support for the design and implementation of work in focus countries to dramatically and sustainably improve immunization service delivery and new vaccine introductions, in collaboration with direct reports and regional manager
4) Improve national and global practices and policies related to new vaccine introductions and service delivery, in collaboration with direct reports and program leadership